Upadacitinib vs. dupilumab in adults with moderate-to-severe atopic dermatitis: analysis of the Heads Up phase III trial

被引：0
|
作者：
Blauvelt, A. [1 ]
Teixeira, H. D. [2 ]
Simpson, E. L. [3 ]
Costanzo, A. [4 ,5 ]
De Bruin-Weller, M. [6 ]
Barbarot, S. [7 ]
Prajapati, V. H. [8 ,9 ,10 ,11 ,12 ,13 ]
Lio, P. [14 ,15 ]
Hu, X. [2 ]
Wu, T. [2 ]
Liu, J. [2 ]
Ladizinski, B. [2 ]
Chu, A. D. [2 ]
Eyerich, K. [16 ,17 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] AbbVie Inc, N Chicago, IL USA
[3] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA
[4] Humanitas Univ, Dept Biomed Sci, Dermatol Unit, Pieve Emanuele, Italy
[5] IRCCS, Humanitas Clin & Res Ctr, Rozzano, Italy
[6] Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Utrecht, Netherlands
[7] Nantes Univ, CHU Nantes, Dept Dermatol, Nantes, France
[8] Univ Calgary, Dept Med, Div Dermatol, Calgary, AB, Canada
[9] Univ Calgary, Dept Pediat, Div Community Pediat, Calgary, AB, Canada
[10] Univ Calgary, Dept Pediat, Div Pediat Rheumatol, Calgary, AB, Canada
[11] Skin Hlth & Wellness Ctr, Calgary, AB, Canada
[12] Dermatol Res Inst, Calgary, AB, Canada
[13] Prob Med Res, Calgary, AB, Canada
[14] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA
[15] Med Dermatol Associates Chicago, Chicago, IL USA
[16] Karolinska Inst, Stockholm, Sweden
[17] Karolinska Univ Hosp, Stockholm, Sweden
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
489
引用
收藏
页码：E123 / E123
页数：1
相关论文
共 50 条
  • [1] UPADACITINIB VERSUS DUPILUMAB IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS OF THE HEADS UP PHASE 3 TRIAL
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 62 - 62
  • [2] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
  • [3] Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study
    Blauvelt, Andrew
    de Bruin-Weller, Marjolein
    Kwatra, Shawn G.
    Gooderham, Melinda J.
    Kim, Brian
    Liu, Yingyi
    Chu, Alvina D.
    Ofori, Sarah
    Platt, Andrew
    Calimlim, Brian M.
    Silverberg, Jonathan, I
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II28 - II29
  • [4] EFFICACY OF UPADACITINIB VS DUPILUMAB FOR MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS OF TIME SPENT IN ITCH RESPONSE STATE FROM THE HEADS UP STUDY
    Blauvelt, Andrew
    de Bruin-Weller, Marjolein S.
    Kwatra, Shawn G.
    Gooderham, Melinda J.
    Kim, Brian
    Liu, Yingyi
    Chu, Alvina
    Oforia, Sarah
    Platt, Andrew
    Calimlim, Brian
    Silverberg, Jonathan I.
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 21 - 21
  • [5] Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
    Beck, Lisa A.
    Thaci, Diamant
    Hamilton, Jennifer D.
    Graham, Neil M.
    Bieber, Thomas
    Rocklin, Ross
    Ming, Jeffrey E.
    Ren, Haobo
    Kao, Richard
    Simpson, Eric
    Ardeleanu, Marius
    Weinstein, Steven P.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    Suarez-Farinas, Mayte
    Hager, Melissa D.
    Stahl, Neil
    Yancopoulos, George D.
    Radin, Allen R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02): : 130 - 139
  • [6] Onset and depth of response with abrocitinib vs. dupilumab in adults with moderate-to-severe atopic dermatitis: analysis of the phase IIIb JADE DARE clinical trial
    Reich, K.
    Valenzuela, F.
    Hong, H. C.
    Eyerich, K.
    Rice, Z. Pressley
    Bhambri, A.
    Guler, E.
    Zhang, F.
    Rojo, R.
    Chan, G.
    Clibborn, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E170 - E170
  • [7] Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study
    Thyssen, Jacob P.
    Rosmarin, David
    Costanzo, Antonio
    Warren, Richard
    Chu, Chia-Yu
    Chovatiya, Raj
    Ladizinski, Barry
    Hu, Xiaofei
    Liu, Yingyi
    Calimlim, Brian
    Nduaka, Chudi
    Vigna, Namita
    Armstrong, April
    DERMATOLOGY, 2025, 241 (01) : 10 - 18
  • [8] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (vol 157, pg 1047, 2021)
    Blauvelt, A.
    Teixeira, H. D.
    Simpson, E. L.
    JAMA DERMATOLOGY, 2022,
  • [9] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (vol 157, pg 1047, 2021)
    Blauvelt, A.
    Teixeira, H. D.
    Simpson, E. L.
    JAMA DERMATOLOGY, 2024, 160 (03) : 370 - 370
  • [10] Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial (vol 157, pg 1047, 2021)
    Blauvelt, A.
    JAMA DERMATOLOGY, 2022, 158 (02) : 219 - 219
12345